MEI Pharma, Inc. (NASDAQ:MEIP – Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $6.57 and traded as low as $6.56. MEI Pharma shares last traded at $6.64, with a volume of 3,005 shares traded. Wall Street Analyst Weigh […]
StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Rating) in a research note published on Sunday. The firm issued a hold rating on the stock. Separately, Piper Sandler lowered MEI Pharma from an overweight rating to a neutral rating in a research note on Friday, February 24th. One analyst has rated the […]
StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Rating) in a report issued on Saturday morning. The brokerage issued a hold rating on the stock. MEIP has been the subject of several other reports. HC Wainwright lowered their target price on MEI Pharma from $100.00 to $40.00 and set a buy rating […]
MEI Pharma, Inc. , a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that, consistent with the Company’s succession planning, Brian. | June 13, 2023
MEI Pharma, Inc. , a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that, in connection with the Company’s previously announced succession. | June 2, 2023